Johnson & Johnson to Invest $55B in US, Build 4 New NC Plants

Johnson & Johnson's Major U.S. Investment: A Boost to Domestic Manufacturing

In a significant move to enhance its manufacturing capabilities, Johnson & Johnson is set to invest over $55 billion in the United States over the next four years. This plan includes the establishment of four new manufacturing facilities, highlighting a broader trend of increased U.S. investments by major corporations.

This initiative follows similar announcements from other companies like Eli Lilly and Co., which also cited the 2017 tax cuts as a motivating factor for expanding their operations stateside. Johnson & Johnson's latest investment marks a 25% increase compared to the previous four years, and it's projected to have an economic impact exceeding $100 billion annually in the U.S.

"Our increased U.S. investment begins with the ground-breaking of a high-tech facility in North Carolina that will not only add U.S.-based jobs but manufacture cutting edge medicines to treat patients in America and around the world," stated Johnson & Johnson Chairman and CEO Joaquin Duato.

The first of the new plants will be situated in Wilson, North Carolina, although the locations of the remaining three facilities remain undisclosed. Alongside these developments, the company plans to enhance existing sites, and advance research and development infrastructure and technology.

Johnson & Johnson's expansion is part of a larger wave of substantial U.S. investments by global corporations. Earlier this year, Taiwan Semiconductor Manufacturing Co. declared its intention to invest $100 billion in the U.S., supplementing a previous $65 billion commitment.

Following suit, Apple has announced plans for a $500 billion investment in the U.S. over the coming four years. This includes hiring 20,000 new employees and establishing a new server factory in Texas, projected to open in 2026, which will play a key role in supporting Apple Intelligence, the company's AI feature suite.